These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The diagnosis of adverse medical events associated with drug treatment. Stephens MD Adverse Drug React Acute Poisoning Rev; 1987; 6(1):1-35. PubMed ID: 3303863 [No Abstract] [Full Text] [Related]
23. [Notification of possible adverse reactions to drugs in medical publications]. Laporte JR; CapellĂ D Med Clin (Barc); 1984 Oct; 83(11):474. PubMed ID: 6503426 [No Abstract] [Full Text] [Related]
24. Adverse drug reaction reporting system: developing a well-monitored program. Kilarski DJ; Ziegler B; Coarse J; Buchanan C Hosp Formul; 1986 Sep; 21(9):949-52. PubMed ID: 10289704 [TBL] [Abstract][Full Text] [Related]
25. Postmarketing surveillance for drug safety: surely we can do better. Griffin MR; Stein CM; Ray WA Clin Pharmacol Ther; 2004 Jun; 75(6):491-4. PubMed ID: 15179403 [No Abstract] [Full Text] [Related]
29. Biological indicator test packs: a survey of user practices. Smith DE J Healthc Mater Manage; 1988; 6(4):38, 40-2. PubMed ID: 10287653 [No Abstract] [Full Text] [Related]
30. The desire to regulate: the wish to discover. Lasagna L Drugs Exp Clin Res; 1987; 13(11):659-64. PubMed ID: 3443041 [TBL] [Abstract][Full Text] [Related]
31. Postmarketing surveillance of adverse drug reactions. Castle WM; Lewis JA Br Med J (Clin Res Ed); 1984 May; 288(6428):1458-9. PubMed ID: 6426604 [No Abstract] [Full Text] [Related]
32. Therapeutic auditing at the national and international level. Westerholm B Br J Clin Pharmacol; 1986; 22 Suppl 1(Suppl 1):55S-59S. PubMed ID: 3567033 [No Abstract] [Full Text] [Related]
33. [Drug surveillance in patients of advanced-age]. Bol Oficina Sanit Panam; 1984 Apr; 96(4):342-52. PubMed ID: 6233994 [No Abstract] [Full Text] [Related]
34. Postmarketing surveillance of adverse reactions to drugs. Rawlins MD Br Med J (Clin Res Ed); 1984 Mar; 288(6421):879-80. PubMed ID: 6423125 [No Abstract] [Full Text] [Related]
35. Techniques of postmarketing surveillance. An overview. Carson JL; Strom BL Med Toxicol; 1986; 1(4):237-46. PubMed ID: 3537618 [No Abstract] [Full Text] [Related]
36. Postmarketing surveillance of adverse reactions to drugs. Inman WHW Br Med J (Clin Res Ed); 1984 Apr; 288(6424):1155-6. PubMed ID: 6424767 [No Abstract] [Full Text] [Related]